These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Amyloid-β 1-42 levels are modified by apolipoprotein E ε4 in Creutzfeldt-Jakob disease in a similar manner as in Alzheimer's disease. Varges D, Jung K, Gawinecka J, Heinemann U, Schmitz M, von Ahsen N, Krasnianski A, Armstrong VW, Zerr I. J Alzheimers Dis; 2011; 23(4):717-26. PubMed ID: 21157024 [Abstract] [Full Text] [Related]
3. LRP-associated protein gene (LRPAP1) and susceptibility to degenerative dementia. Pandey P, Pradhan S, Mittal B. Genes Brain Behav; 2008 Nov; 7(8):943-50. PubMed ID: 18721259 [Abstract] [Full Text] [Related]
4. Polymorphisms in the prion protein gene and in the doppel gene increase susceptibility for Creutzfeldt-Jakob disease. Croes EA, Alizadeh BZ, Bertoli-Avella AM, Rademaker T, Vergeer-Drop J, Dermaut B, Houwing-Duistermaat JJ, Wientjens DP, Hofman A, Van Broeckhoven C, van Duijn CM. Eur J Hum Genet; 2004 May; 12(5):389-94. PubMed ID: 14970845 [Abstract] [Full Text] [Related]
5. Gene variations in GSTM3 are a risk factor for Alzheimer's disease. Hong GS, Heun R, Jessen F, Popp J, Hentschel F, Kelemen P, Schulz A, Maier W, Kölsch H. Neurobiol Aging; 2009 May; 30(5):691-6. PubMed ID: 17904251 [Abstract] [Full Text] [Related]
7. Polymorphisms at the beta2-adrenergic receptor gene influence Alzheimer's disease susceptibility. Yu JT, Tan L, Ou JR, Zhu JX, Liu K, Song JH, Sun YP. Brain Res; 2008 May 19; 1210():216-22. PubMed ID: 18423577 [Abstract] [Full Text] [Related]
8. Genetic epidemiology of Creutzfeldt-Jakob disease in Europe. EUROCJD Group. Rev Neurol (Paris); 2001 Jul 19; 157(6-7):633-7. PubMed ID: 11458182 [Abstract] [Full Text] [Related]
15. Apolipoprotein E gene polymorphism and previous alcohol withdrawal seizures. Wilhelm J, von Ahsen N, Hillemacher T, Bayerlein K, Frieling H, Kornhuber J, Bleich S. J Psychiatr Res; 2007 Nov 21; 41(10):871-5. PubMed ID: 16959267 [Abstract] [Full Text] [Related]
16. The APOE polymorphism and 1-year outcome in ischemic stroke: genotype-gender interaction. Gromadzka G, Baranska-Gieruszczak M, Sarzynska-Dlugosz I, Ciesielska A, Czlonkowska A. Acta Neurol Scand; 2007 Dec 21; 116(6):392-8. PubMed ID: 17986098 [Abstract] [Full Text] [Related]
17. Genetic analysis of tumor necrosis factor-alpha (TNF-alpha) G-308A and Saitohin Q7R polymorphisms with Alzheimer's disease. Wang B, Zhou S, Yang Z, Xie YC, Wang J, Zhang P, Lv Z, Zheng C, Ma X. J Neurol Sci; 2008 Jul 15; 270(1-2):148-51. PubMed ID: 18396294 [Abstract] [Full Text] [Related]
18. Association of the hOGG1 Ser326Cys polymorphism with sporadic amyotrophic lateral sclerosis. Coppedè F, Mancuso M, Lo Gerfo A, Carlesi C, Piazza S, Rocchi A, Petrozzi L, Nesti C, Micheli D, Bacci A, Migliore L, Murri L, Siciliano G. Neurosci Lett; 2007 Jun 13; 420(2):163-8. PubMed ID: 17531381 [Abstract] [Full Text] [Related]